• Survey highlights interest in diet’s effects on RA

    on February 23rd, 2017
    FROM ARTHRITIS CARE & RESEARCH Nearly one-quarter of patients with long-standing rheumatoid arthritis who participated in a recent survey reported that their diets affect their RA symptoms. Of 217 participants with a median disease duration of 17 years, 52 (24%) reported that certain foods eithe[...]
  • Pilot trial of first in kind biologic shows RA treatment potential

    on February 23rd, 2017
    FROM ANNALS OF THE RHEUMATIC DISEASES The novel biologic mavrilimumab that targets the GM-CSF pathway has shown therapeutic potential in the treatment of rheumatoid arthritis in a proof-of-concept trial, particularly in patients who have failed to respond to biologics that target other pathways. Wri[...]
  • Sarcoidosis doubles hospitalized infection risk

    on February 23rd, 2017
    FROM ANNALS OF THE AMERICAN THORACIC SOCIETY Persons with sarcoidosis were found to have double the risk of hospitalization, compared with age-matched controls in a population-based cohort study that also linked glucocorticoid use with an increased risk of hospitalization in this group. Using data f[...]
  • Methotrexate prolonged efficacy of steroid injections in oligoarticular JIA

    on February 22nd, 2017
    Oral methotrexate prolonged and slightly boosted the efficacy of intra-articular corticosteroid injections in children with oligoarticular juvenile idiopathic arthritis without causing serious adverse effects, based on the results of a first-in-kind multicenter, randomized, open-label trial. “This[...]
  • Comparison of immunosuppressants for early diffuse systemic sclerosis yields mixed results

    on February 22nd, 2017
    FROM ANNALS OF THE RHEUMATIC DISEASES Placing patients who have early diffuse cutaneous systemic sclerosis (dcSSc ) on an immunosuppressant regimen can have a beneficial, but not necessarily sustainable, impact, according to findings from the European Scleroderma Observational Study. “At present, [...]
  • Methotrexate for RA: ‘We continue to learn more about this fascinating drug’

    on February 16th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – “When I started working with methotrexate in 1982, I never would have predicted that methotrexate would become the standard of care in treating rheumatoid arthritis. There’s just no way,” Michae[...]
  • Opinions vary considerably on withdrawing drugs in clinically inactive JIA

    on February 15th, 2017
    FROM JOURNAL OF RHEUMATOLOGY A wide range of attitudes and practices for the process of withdrawing medications in pediatric patients with clinically inactive juvenile idiopathic arthritis (JIA) exist among clinician members of the Childhood Arthritis and Rheumatology Research Alliance (CARRA), acco[...]
  • Osteoarthritis in hip or knee can increase diabetes risk

    on February 14th, 2017
    FROM THE CRA SCIENTIFIC CONFERENCE Individuals who have osteoarthritis in the hip or knee are significantly more likely to develop diabetes than are people without the condition, according to findings from a population-based cohort study. The relationship between osteoarthritis (OA) and new-onset di[...]
  • Hypertension in SLE pregnancy: Is it lupus flare or preeclampsia?

    on February 14th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – No hard and fast test exists that would enable a physician to tell a flare of systemic lupus erythematosus from preeclampsia in a pregnant lupus patient who becomes hypertensive and ill, but there are[...]
  • Guideline: Prioritize nondrug therapies for low back pain

    on February 13th, 2017
    FROM ANNALS OF INTERNAL MEDICINE Clinicians and patients should prioritize nonpharmacologic therapies for low back pain of any duration, according to an updated guideline from the American College of Physicians. For acute and subacute low back pain, first-line choices include heat, massage, acupunct[...]
  • Ultrasound guidance of early RA therapy doesn’t improve outcomes

    on February 13th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – Rheumatologists who use musculoskeletal ultrasound to help guide a treat-to-target strategy in early rheumatoid arthritis may want to reconsider that practice in light of the results of a recent rando[...]
  • Specific polymorphisms excluded in hemophilic arthropathy

    on February 13th, 2017
    FROM EAHAD 2017 Carriers of a hemochromatosis (HFE) gene mutation or a long (GT)n-repeat length within the HMOX1 promoter regions did not appear to have an increase in hemophilic arthropathy. In 201 blood samples from patients with severe hemophilia A or B and 37 from patients with moderate disease,[...]
  • ACR guidelines on HBV screening called inadequate

    on February 13th, 2017
    EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM SNOWMASS, COLO. (FRONTLINE MEDICAL NEWS) – The ACR guidelines for hepatitis B virus screening prior to starting immunosuppressive therapy are sorely in need of an overhaul, Leonard H. Calabrese, MD, asserted at the Winter Rheumatology Symposiu[...]
Back to top